These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22398127)

  • 1. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
    Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
    Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study.
    Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP
    Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
    Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
    Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.
    Wu RR; Zhao JP; Jin H; Shao P; Fang MS; Guo XF; He YQ; Liu YJ; Chen JD; Li LH
    JAMA; 2008 Jan; 299(2):185-93. PubMed ID: 18182600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin for prevention of weight gain and insulin resistance with olanzapine: a double-blind placebo-controlled trial.
    Baptista T; Martínez J; Lacruz A; Rangel N; Beaulieu S; Serrano A; Arapé Y; Martinez M; de Mendoza S; Teneud L; Hernández L
    Can J Psychiatry; 2006 Mar; 51(3):192-6. PubMed ID: 16618011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin treatment of antipsychotic-induced dyslipidemia: an analysis of two randomized, placebo-controlled trials.
    Wu RR; Zhang FY; Gao KM; Ou JJ; Shao P; Jin H; Guo WB; Chan PK; Zhao JP
    Mol Psychiatry; 2016 Nov; 21(11):1537-1544. PubMed ID: 26809842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended release metformin for metabolic control assistance during prolonged clozapine administration: a 14 week, double-blind, parallel group, placebo-controlled study.
    Carrizo E; Fernández V; Connell L; Sandia I; Prieto D; Mogollón J; Valbuena D; Fernández I; de Baptista EA; Baptista T
    Schizophr Res; 2009 Aug; 113(1):19-26. PubMed ID: 19515536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial.
    Anagnostou E; Aman MG; Handen BL; Sanders KB; Shui A; Hollway JA; Brian J; Arnold LE; Capano L; Hellings JA; Butter E; Mankad D; Tumuluru R; Kettel J; Newsom CR; Hadjiyannakis S; Peleg N; Odrobina D; McAuliffe-Bellin S; Zakroysky P; Marler S; Wagner A; Wong T; Macklin EA; Veenstra-VanderWeele J
    JAMA Psychiatry; 2016 Sep; 73(9):928-37. PubMed ID: 27556593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
    Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F
    J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of adjunctive metformin on metabolic traits in nondiabetic clozapine-treated patients with schizophrenia and the effect of metformin discontinuation on body weight: a 24-week, randomized, double-blind, placebo-controlled study.
    Chen CH; Huang MC; Kao CF; Lin SK; Kuo PH; Chiu CC; Lu ML
    J Clin Psychiatry; 2013 May; 74(5):e424-30. PubMed ID: 23759461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
    Arman S; Sadramely MR; Nadi M; Koleini N
    Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipsychotic-induced weight gain in patients with schizophrenia.
    Venkatasubramanian G
    JAMA; 2008 Apr; 299(16):1899; author reply 1899-900. PubMed ID: 18430906
    [No Abstract]   [Full Text] [Related]  

  • 15. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine.
    Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A
    BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population.
    Rado J; von Ammon Cavanaugh S
    J Clin Psychopharmacol; 2016 Apr; 36(2):163-8. PubMed ID: 26872112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain.
    Ellinger LK; Ipema HJ; Stachnik JM
    Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for Weight Gain and Metabolic Abnormalities Associated With Antipsychotic Treatment: Meta-Analysis of Randomized Placebo-Controlled Trials.
    Zheng W; Li XB; Tang YL; Xiang YQ; Wang CY; de Leon J
    J Clin Psychopharmacol; 2015 Oct; 35(5):499-509. PubMed ID: 26280837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin counter-regulatory factors, fibrinogen and C-reactive protein during olanzapine administration: effects of the antidiabetic metformin.
    Baptista T; Sandia I; Lacruz A; Rangel N; de Mendoza S; Beaulieu S; Contreras Q; Galeazzi T; Vargas D
    Int Clin Psychopharmacol; 2007 Mar; 22(2):69-76. PubMed ID: 17293706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topiramate for prevention of olanzapine associated weight gain and metabolic dysfunction in schizophrenia: a double-blind, placebo-controlled trial.
    Narula PK; Rehan HS; Unni KE; Gupta N
    Schizophr Res; 2010 May; 118(1-3):218-23. PubMed ID: 20207521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.